Category Biodiversity/Genetic Resources/Biotech

Indigenous Peoples Rights’ Reaffirmed By UN Rapporteur, Panellists, At WIPO

The United Nations Special Rapporteur on the Rights of Indigenous People, James Anaya, was invited to speak at the opening of the World Intellectual Property Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (IGC) yesterday. Along with other indigenous peoples representatives, he called for more participation of indigenous peoples in the process and a focus on the protection of their traditional knowledge, while WIPO raised alarm on the almost thorough depletion of the voluntary fund allowing the participation of indigenous peoples.

Expiring GMO Patents Raise Regulatory Issues; Private Sector Takes Measures

A number of patents on genetically modified organisms (GMOs) in agriculture will expire in the coming years and this could be a problem for the biotechnology industry in terms of regulatory authorisations. A private sector initiative has recently been launched to address the issue.

FAO: New GMOs Rising In Developing Countries; Public Sector Key

Contributions of participants at a recent e-conference organised by the Food and Agriculture Organization of the United Nations (FAO) on new genetically modified organisms show that a considerable number of new GMOs are likely to be released in developing countries in the next five years.

Plant Variety Protection Meets Resistance in Developing Countries; Consultations Coming

Plant variety protection has raised concerns in Africa and in Latin America, and further developments are expected in 2013.

Polio Talks At WHO Board: Between Progress Made, The Final Push And The Role Of Partnership

On the occasion of the 132nd session of the World Health Organization Executive Board last week, delegations welcomed the efforts made by the international community to eradicate poliomyelitis (polio), but saw room for improvement. As a way forward, they looked to the key role played by WHO partners.

Intense Drafting Session Ahead For WIPO Delegates Working On Genetic Resources

Next week, World Intellectual Property Organization delegates will convene for the first committee meeting of 2013. First up is the protection of genetic resources from misappropriation, and the goal of the week is to bridge gaps so they can construct a text that could become an international instrument on protection.

Genetic Resources And Traditional Knowledge : Getting The Rules Right For Agriculture: A Key Challenge For WIPO’s IGC

An essential relationship exists among the conservation, development and use of genetic resources, sustainable agriculture and food security. There is an equally essential relationship between the conservation, development and use of genetic resources and small scale-farmers. The strength and effectiveness of any treaty addressing IP and genetic resources depends on the meaningful participation of small-scale farmers, and those that can represent them, as in the treaty deliberations continuing next week at WIPO, write Susan Bragdon and Lynn Finnegan.

WHO Board Approves Resolution On Neglected Diseases; Sets Action On Substandard Medicines

The World Health Organization Executive Board today approved a modified resolution on neglected tropical diseases – after removing a reference to a working group on R&D for neglected diseases as “irrelevant”. The Board also discussed and took note of a report on poor quality medical products in the supply chain, and agreed to set another meeting on the issue before the May World Health Assembly, as well as set up a separate group on behaviours that lead to this problem.

Debate Erupts At WHO Over “Consensus” On Financing R&D For The Poor

World Health Organization members on Friday held a tense discussion over legal and political aspects of a consensus reached by a small number of member states in November on implementing a plan to address the global lack of research and development for neglected diseases predominantly afflicting poor populations. The discussion may continue today, with the linkage of an agenda item on neglected tropical diseases and the report of an expert working group offering numerous ideas for addressing the problem.

WHO Plan For Pandemic Flu Proceeds With Questions

The World Health Organization has not completed negotiations with companies on a formula for contribute toward the new WHO framework for pandemic influenza. But companies are paying to access the virus anyway. In its meeting this week, the WHO Executive Board has addressed a range of issues such as pandemic influenza, but so far it has delayed discussion on another contentious topic: substandard/counterfeit medical products.